These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34783147)

  • 1. Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity.
    Mahmoud Marie RE; Adel AM; Abd El-Fadeal NM; Eyada MMK
    J Cosmet Dermatol; 2022 Aug; 21(8):3515-3521. PubMed ID: 34783147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity.
    Atwa MA; Ali SMM; Youssef N; Mahmoud Marie RE
    J Cosmet Dermatol; 2021 Aug; 20(8):2640-2644. PubMed ID: 33355977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
    Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
    Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.
    Vaccaro M; Cicero F; Mannucci C; Calapai G; Spatari G; Barbuzza O; Cannavò SP; Gangemi S
    Arch Dermatol Res; 2016 Sep; 308(7):527-30. PubMed ID: 27388717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the relation between vitiligo, Interleukin 17, and serum amyloid A.
    Ahmed AAE; Mikhael NW; Elfallah AA; Hamed AM
    J Cosmet Dermatol; 2022 Nov; 21(11):6428-6433. PubMed ID: 36005895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease.
    Sushama S; Dixit N; Gautam RK; Arora P; Khurana A; Anubhuti A
    J Cosmet Dermatol; 2019 Feb; 18(1):337-341. PubMed ID: 29504235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients.
    Elela MA; Hegazy RA; Fawzy MM; Rashed LA; Rasheed H
    Eur J Dermatol; 2013; 23(3):350-5. PubMed ID: 23797460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
    Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
    Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant role of innate pro-inflammatory cytokines in vitiligo disease.
    Gholijani N; Yazdani MR; Dastgheib L
    Arch Dermatol Res; 2020 Mar; 312(2):123-131. PubMed ID: 31620869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17, rather than Th1 cell proportion, is closely correlated with elevated disease severity, higher inflammation level, and worse prognosis in sepsis patients.
    Liu Y; Wang X; Yu L
    J Clin Lab Anal; 2021 May; 35(5):e23753. PubMed ID: 33704828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1/17 cells.
    Zhang L; Kang Y; Chen S; Wang L; Jiang M; Xiang L
    J Dermatol Sci; 2019 Feb; 93(2):92-100. PubMed ID: 30655106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
    Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
    J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases.
    Czarnowicki T; He H; Leonard A; Kim HJ; Kameyama N; Pavel AB; Li R; Estrada Y; Wen HC; Kimmel GW; Kim HJ; Chima M; Lebwohl M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Jun; 143(6):2095-2107. PubMed ID: 30576756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
    J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1/Th2/Th17-related cytokines.
    Li Y; Jie Y; Wang X; Lu J
    BMC Immunol; 2021 Jun; 22(1):42. PubMed ID: 34176464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis.
    Kim J; Kang S; Kim J; Kwon G; Koo S
    Ann Lab Med; 2013 Jan; 33(1):52-9. PubMed ID: 23301223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.